
Top Picks
Sonnet BioTherapeutics Holdings Inc (SONN) 14-day ATR is 0.07: This Stock is Set to Soar Above its Peers
As on Wednesday, Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) got off with the flyer as it spiked 0.43% to $1.16, before settling in for the